Literature DB >> 28920710

Use of strong opioids for chronic pain in osteoarthritis: an insight into the Latin American reality.

Miguel Angel Ruiz Iban1, Javier Benavides2, Juan Pablo Forero3, Sacha Bittelman4, Rafael Martinez5, Miguel Angel Mite6, Jorge Diaz Heredia1, Sergio Ulloa7, Mauro Marcelo Lizárraga Ferrand8.   

Abstract

INTRODUCTION: Osteoarthritis is the most common cause of arthritis and one of the main causes of chronic pain. Although opioids are frequently employed for chronic pain treatment, their usage for osteoarthritis pain remains controversial due to the associated adverse effects. Most guidelines reserve their use for refractory pain in patients with hip and knee osteoarthritis. The situation is even more complex in Latin America, where the prevalence of insufficient pain treatment is high because of the limited availability and use of strong opioids. Areas covered: In this article we review the epidemiology of osteoarthritis, its socioeconomic burden, its impact as a chronic pain cause and the pharmacological treatment options, giving emphasis to the role of strong opioids, their safety and efficacy, especially in Latin American countries, where restrictions regulate their usage. Expert commentary: Usage of strong opioids is safe and effective in the short-term management of osteoarthritis with moderate to severe pain, when other pharmacological treatments are inadequate and surgery is contraindicated, provided their use adheres to existing guidelines. Educational programs for patients and physicians and further research on treating chronic pain with opioids should be implemented to reduce adverse effects and improve care quality.

Entities:  

Keywords:  Chronic pain; Latin America; osteoarthritis; strong opioids

Mesh:

Substances:

Year:  2017        PMID: 28920710     DOI: 10.1080/17512433.2018.1381556

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  5 in total

1.  Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.

Authors:  Antoni Sicras-Mainar; Carlos Tornero-Tornero; Francisco Vargas-Negrín; Isabel Lizarraga; Javier Rejas-Gutierrez
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-17       Impact factor: 5.346

2.  Trends in Opioid Use in a Cohort of Patients with Rheumatoid Arthritis.

Authors:  Manuel E Machado-Duque; Diana Marcela Ramírez-Valencia; María Mónica Murillo-Muñoz; Jorge E Machado-Alba
Journal:  Pain Res Manag       Date:  2020-07-16       Impact factor: 3.037

Review 3.  Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain.

Authors:  Joseph V Pergolizzi; Robert Taylor; Jo Ann LeQuang; Argelia Lara; Andres Hernandez Ortiz; Miguel A Ruiz Iban
Journal:  Pain Ther       Date:  2019-05-17

Review 4.  Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?

Authors:  Elaheh Mianehsaz; Hamid Reza Mirzaei; Maryam Mahjoubin-Tehran; Alireza Rezaee; Roxana Sahebnasagh; Mohammad Hossein Pourhanifeh; Hamed Mirzaei; Michael R Hamblin
Journal:  Stem Cell Res Ther       Date:  2019-11-21       Impact factor: 6.832

5.  Complexity Assessment of Chronic Pain in Elderly Knee Osteoarthritis Based on Neuroimaging Recognition Techniques.

Authors:  Xuemin Wu; Jingjing Liu; Min Liu; Tao Wu
Journal:  Comput Math Methods Med       Date:  2021-11-28       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.